Epicardial adipose tissue: A long-overlooked marker of risk of cardiovascular disease

Atherosclerosis

Volumn 229, Issue 1, 2013, Pages 32-33

  Raggi, Paolo ^a   Alakija, Pauline ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiovascular disease risk; Epicardial adipose tissue

Indexed keywords

ADIPOSE TISSUE; ARTERIAL STIFFNESS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; EPICARDIUM; HEART MUSCLE PERFUSION; INFLAMMATORY INFILTRATE; LIPID STORAGE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAST CELL; NOTE; PERICARDIUM; PRIORITY JOURNAL; PULSE WAVE; SUBCUTANEOUS FAT; T LYMPHOCYTE;

ADIPOSE TISSUE; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; PERICARDIUM; VASCULAR STIFFNESS;

EID: 84879422938     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.02.030     Document Type: Note

References (20)

1. Choi T.Y., et al. Relation of vascular stiffness with epicardial and pericardial adipose tissues, and coronary atherosclerosis. Atherosclerosis 2013, 229(1):118-123.
2. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 1956, 4:20-34.
3. Després J.P. Body fat distribution and risk of cardiovascular disease. Circulation 2012, 126:1301-1313.
4. Mazurek T., Zhang L.F., Zalewski A., et al. Human epicardial adipose tissue is a source of inflammatory markers. Circulation 2003, 108:2460-2466.
5. Mohlenkamp S., Hort W., Ge J., Erbel R. Update on myocardial bridging. Circulation 2002, 106:2616-2622.
6. Alegria J.R., Herrmann J., Holmes D.R., Lerman A., Rihal C.S. Myocardial bridging. Eur Heart J 2002, 26:1159-1168.
7. Sacks H.S., Fain J.N. Human epicardial adipose tissue: a review. Am Heart J 2007, 153:907-917.
8. Taguchi R., Takasu J., Itani Y., et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 2001, 157:203-209.
9. Janik M., Hartlage G., Alexopoulos N., et al. Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. JNucl Cardiol 2010, 17:841-847.
10. Alexopoulos N., McLean D.S., Janik M., Arepalli C.D., Stillman A.E., Raggi P. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010, 210:150-154.
11. Tavora F., Kutys R., Li L., Ripple M., Fowler D., Burke A. Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis. Cardiovasc Pathol 2010, 19:e61-e68.
12. Ding J., Hsu F.C., Harris T.B., et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009, 90:499-504.
13. Mahabadi A.A., Berg M.H., Lehmann N., et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. JAm Coll Cardiol 2013 Feb 14, [Epub ahead of print]. 10.1016/j.jacc.2012.11.062.
14. Sutton-Tyrrell K., Newman A., Simonsick E.M., et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001, 38:429-433.
15. Cavalcante J.L., Tamarappoo B.K., Hachamovitch R., et al. Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction. Am J Cardiol 2012, 110(12):1793-1798. 10.1016/j.amjcard.2012.07.045.
16. Hsu P.C., Tsai W.C., Lin T.H., et al. Association of arterial stiffness and electrocardiography-determined left ventricular hypertrophy with left ventricular diastolic dysfunction. PLoS One 2012, 7(11):e49100.
17. Nakazato R., Rajani R., Cheng V.Y., et al. Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis 2012, 220:139-144.
18. Alexopoulos N, Melek BH, Arepalli C. Effect of intensive versus moderate lipid-lowering therapy on progression of epicardial adipose tissue volume in hyperlipidemic postmenopausal women. A substudy of the BELLES (Beyond Endorsed Lipid Lowering with EBT Scanning) trial. J Am Coll Cardiol, http://dx.doi.org/10.1016/j.jacc.2012.12.051.
19. Martín-Ventura J.L., Blanco-Colio L.M., Gómez-Hernández A., et al. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke 2005, 36(8):1796-1800.
20. Blanco-Colio L.M., Martín-Ventura J.L., Gómez-Guerrero C., et al. Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk. Eur J Pharmacol 2008, 586(1-3):259-265. 10.1016/j.ejphar.2008.02.042.